Talukdar Lavina bought MNPR
March 4, 2025 · Form 4 insider transaction
Talukdar Lavina bought 5,683 shares of Monopar Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,683
Price
$0.00
Total value
N/A
InsiderTalukdar Lavina
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMarch 4, 2025
Filing dateMarch 7, 2025
Shares owned after5,683
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options vest 25% quarterly on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025